CBOE vs VRDN · P/E 24, rev $2.72B vs rev $425.0K
Cboe Global Markets Inc (CBOE) versus Viridian Therapeutics Inc (VRDN) — a side-by-side from cached financials, not a winner call.
Cboe Global Markets Inc (CBOE) is a financial data & stock exchanges company listed on US.
Viridian Therapeutics Inc (VRDN) is a biotechnology company listed on US.
Latest reported CBOE revenue for 2026-06-30 was $2.72B. Net income was $738.8M. CBOE currently screens at market cap $29.50B and trailing P/E 24.1.
Latest reported VRDN revenue for 2026-06-30 was $425.0K. Net income was -$232.0M. VRDN currently screens at market cap $1.39B.
CBOE currently screens at market cap $29.50B and trailing P/E 24.1. VRDN currently screens at market cap $1.39B.
Not investment advice. Open the CBOE and VRDN stock pages for the full models.
Not investment advice.